Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;13(3):225-9.
doi: 10.1097/mco.0b013e32833862df.

Signaling pathways perturbing muscle mass

Affiliations
Review

Signaling pathways perturbing muscle mass

David J Glass. Curr Opin Clin Nutr Metab Care. 2010 May.

Abstract

Purpose of review: To discuss the mechanisms of muscle loss during cachexia.

Recent findings: Cachexia can be defined as a wasting of lean body mass that cannot be reversed nutrionally, indicating a dysregulation in the pathways maintaining body composition. In skeletal muscle, during cachexia, there is an upregulation of protein degradation. A search for transcriptional markers of muscle atrophy led to the discovery of the E3 ubiquitin ligases MuRF1 and MAFbx (also called Atrogin-1). These genes are upregulated in multiple models of atrophy and cachexia. They target particular protein substrates for degradation via the ubiquitin/proteasome pathway. The insulin-like growth factor-1 can block the transcriptional upregulation of MuRF1 and MAFbx via the phosphatidylinositol-3 kinase/Akt/Foxo pathway. MuRF1's substrates include several components of the sarcomeric thick filament, including myosin heavy chain. Thus, by blocking MuRF1, insulin-like growth factor-1 prevents the breakdown of the thick filament, particularly myosin heavy chain, which is asymmetrically lost in settings of cortisol-linked skeletal muscle atrophy. Insulin-like growth factor-1/phosphatidylinositol-3 kinase/Akt signaling also dominantly inhibits the effects of myostatin, which is a member of the transforming growth factor-[beta] family of proteins. Deletion or inhibition of myostatin causes a significant increase in skeletal muscle size. Recently, myostatin has been shown to act both by inhibiting gene activation associated with differentiation, even when applied to postdifferentiated myotubes, and by blocking the phosphatidylinositol-3 kinase/Akt pathway.

Summary: These findings will help to define strategies to treat cachexia.

PubMed Disclaimer

Similar articles

Cited by

  • Changes in liver gluconeogenesis during the development of Walker-256 tumour in rats.
    Moreira CC, Cassolla P, Dornellas AP, de Morais H, de Souza CO, Borba-Murad GR, Bazotte RB, de Souza HM. Moreira CC, et al. Int J Exp Pathol. 2013 Feb;94(1):47-55. doi: 10.1111/iep.12002. Int J Exp Pathol. 2013. PMID: 23317353 Free PMC article.
  • TWEAK and TRAF6 regulate skeletal muscle atrophy.
    Kumar A, Bhatnagar S, Paul PK. Kumar A, et al. Curr Opin Clin Nutr Metab Care. 2012 May;15(3):233-9. doi: 10.1097/MCO.0b013e328351c3fc. Curr Opin Clin Nutr Metab Care. 2012. PMID: 22366923 Free PMC article. Review.
  • The landscape of aging.
    Cai Y, Song W, Li J, Jing Y, Liang C, Zhang L, Zhang X, Zhang W, Liu B, An Y, Li J, Tang B, Pei S, Wu X, Liu Y, Zhuang CL, Ying Y, Dou X, Chen Y, Xiao FH, Li D, Yang R, Zhao Y, Wang Y, Wang L, Li Y, Ma S, Wang S, Song X, Ren J, Zhang L, Wang J, Zhang W, Xie Z, Qu J, Wang J, Xiao Y, Tian Y, Wang G, Hu P, Ye J, Sun Y, Mao Z, Kong QP, Liu Q, Zou W, Tian XL, Xiao ZX, Liu Y, Liu JP, Song M, Han JJ, Liu GH. Cai Y, et al. Sci China Life Sci. 2022 Dec;65(12):2354-2454. doi: 10.1007/s11427-022-2161-3. Epub 2022 Sep 2. Sci China Life Sci. 2022. PMID: 36066811 Free PMC article. Review.
  • COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans.
    Levine S, Bashir MH, Clanton TL, Powers SK, Singhal S. Levine S, et al. J Appl Physiol (1985). 2013 May;114(9):1235-45. doi: 10.1152/japplphysiol.01121.2012. Epub 2012 Dec 20. J Appl Physiol (1985). 2013. PMID: 23264538 Free PMC article. Review.
  • Nandrolone normalizes determinants of muscle mass and fiber type after spinal cord injury.
    Wu Y, Zhao J, Zhao W, Pan J, Bauman WA, Cardozo CP. Wu Y, et al. J Neurotrauma. 2012 May 20;29(8):1663-75. doi: 10.1089/neu.2011.2203. Epub 2012 Apr 16. J Neurotrauma. 2012. PMID: 22208735 Free PMC article.

MeSH terms